| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Joint Deformities, Acquired | 1 | 2018 | 4 | 0.78 | Why? |
| Hepatitis E virus | 2 | 2017 | 306 | 0.65 | Why? |
| Pakistan | 18 | 2021 | 2302 | 0.63 | Why? |
| Hepatitis E | 2 | 2017 | 319 | 0.62 | Why? |
| Meningococcal Infections | 1 | 2018 | 216 | 0.59 | Why? |
| Containment of Biohazards | 1 | 2020 | 762 | 0.53 | Why? |
| Vaccines, Subunit | 1 | 2018 | 1088 | 0.48 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.38 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2018 | 2262 | 0.33 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.33 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.29 | Why? |
| Dengue | 4 | 2020 | 1565 | 0.28 | Why? |
| Evolution, Molecular | 2 | 2017 | 3691 | 0.27 | Why? |
| Rotavirus Infections | 2 | 2019 | 355 | 0.27 | Why? |
| Computational Biology | 2 | 2018 | 4514 | 0.26 | Why? |
| Mutation, Missense | 3 | 2021 | 863 | 0.26 | Why? |
| Measles | 2 | 2021 | 608 | 0.25 | Why? |
| Isoniazid | 2 | 2019 | 105 | 0.22 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.22 | Why? |
| Viral Nonstructural Proteins | 1 | 2018 | 4810 | 0.21 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 1115 | 0.21 | Why? |
| Kanamycin | 1 | 2019 | 15 | 0.20 | Why? |
| Ofloxacin | 1 | 2019 | 23 | 0.20 | Why? |
| Humerus | 2 | 2018 | 19 | 0.20 | Why? |
| Drug Resistance, Bacterial | 3 | 2021 | 1414 | 0.20 | Why? |
| Bacteriological Techniques | 2 | 2019 | 239 | 0.20 | Why? |
| Growth Plate | 1 | 2018 | 4 | 0.20 | Why? |
| Mycobacterium tuberculosis | 2 | 2019 | 1164 | 0.19 | Why? |
| Amputees | 1 | 2018 | 19 | 0.19 | Why? |
| Osteotomy | 1 | 2018 | 30 | 0.19 | Why? |
| Salmonella paratyphi A | 1 | 2018 | 22 | 0.19 | Why? |
| Paratyphoid Fever | 1 | 2018 | 19 | 0.19 | Why? |
| Rotavirus | 2 | 2019 | 329 | 0.19 | Why? |
| Staphylococcus haemolyticus | 1 | 2017 | 3 | 0.18 | Why? |
| Shoulder Joint | 1 | 2018 | 57 | 0.18 | Why? |
| Burkholderia | 1 | 2017 | 5 | 0.18 | Why? |
| Public Health Surveillance | 3 | 2021 | 3129 | 0.18 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.18 | Why? |
| Pseudomonas putida | 1 | 2017 | 12 | 0.18 | Why? |
| Salmonella typhi | 1 | 2018 | 98 | 0.17 | Why? |
| Epidemiology | 1 | 2020 | 216 | 0.17 | Why? |
| Catheters | 1 | 2017 | 93 | 0.16 | Why? |
| Typhoid Fever | 1 | 2018 | 139 | 0.16 | Why? |
| Genetic Variation | 2 | 2021 | 3919 | 0.16 | Why? |
| Antigenic Variation | 1 | 2017 | 249 | 0.16 | Why? |
| Multigene Family | 1 | 2017 | 377 | 0.16 | Why? |
| Vascular Endothelial Growth Factor C | 1 | 2015 | 8 | 0.16 | Why? |
| Lymphangiogenesis | 1 | 2015 | 6 | 0.16 | Why? |
| Rifampin | 1 | 2018 | 276 | 0.15 | Why? |
| Vascular Endothelial Growth Factor D | 1 | 2015 | 38 | 0.15 | Why? |
| Pharmacogenetics | 1 | 2017 | 222 | 0.15 | Why? |
| Amputation | 1 | 2018 | 331 | 0.15 | Why? |
| Autophagy-Related Proteins | 1 | 2017 | 157 | 0.15 | Why? |
| Caliciviridae Infections | 1 | 2019 | 229 | 0.15 | Why? |
| Systems Biology | 1 | 2018 | 320 | 0.15 | Why? |
| Microbial Sensitivity Tests | 3 | 2019 | 2886 | 0.15 | Why? |
| Access to Information | 1 | 2020 | 483 | 0.15 | Why? |
| RNA Helicases | 1 | 2018 | 413 | 0.15 | Why? |
| Quantitative Structure-Activity Relationship | 1 | 2017 | 209 | 0.15 | Why? |
| Carcinoma in Situ | 1 | 2015 | 58 | 0.15 | Why? |
| Public Health Practice | 2 | 2020 | 945 | 0.14 | Why? |
| Norovirus | 1 | 2019 | 294 | 0.14 | Why? |
| Antitubercular Agents | 2 | 2019 | 775 | 0.14 | Why? |
| Chemokines | 1 | 2021 | 1095 | 0.14 | Why? |
| Chikungunya Fever | 1 | 2019 | 345 | 0.14 | Why? |
| Protein Stability | 1 | 2017 | 756 | 0.14 | Why? |
| Abortion, Spontaneous | 1 | 2020 | 776 | 0.14 | Why? |
| Receptors, Immunologic | 1 | 2018 | 555 | 0.14 | Why? |
| Databases, Genetic | 2 | 2017 | 1127 | 0.14 | Why? |
| Biofilms | 1 | 2017 | 304 | 0.14 | Why? |
| Adaptation, Physiological | 1 | 2017 | 359 | 0.14 | Why? |
| Pneumococcal Infections | 1 | 2020 | 562 | 0.13 | Why? |
| Gastroenteritis | 1 | 2019 | 489 | 0.13 | Why? |
| Capacity Building | 1 | 2020 | 683 | 0.13 | Why? |
| Drug Resistance, Neoplasm | 1 | 2017 | 447 | 0.13 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.13 | Why? |
| Carcinoma, Transitional Cell | 1 | 2015 | 198 | 0.13 | Why? |
| Sputum | 2 | 2019 | 1720 | 0.13 | Why? |
| Social Networking | 1 | 2020 | 737 | 0.13 | Why? |
| Catheter-Related Infections | 1 | 2017 | 381 | 0.13 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2018 | 433 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Heart Valve Diseases | 1 | 2017 | 355 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2021 | 843 | 0.12 | Why? |
| Pseudomonas Infections | 1 | 2017 | 425 | 0.12 | Why? |
| Leukemia | 1 | 2017 | 598 | 0.12 | Why? |
| Endocarditis, Bacterial | 1 | 2017 | 344 | 0.12 | Why? |
| Cooperative Behavior | 1 | 2020 | 1216 | 0.12 | Why? |
| Neovascularization, Pathologic | 1 | 2015 | 305 | 0.11 | Why? |
| Disease Outbreaks | 4 | 2020 | 27595 | 0.11 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.11 | Why? |
| Anti-Bacterial Agents | 5 | 2021 | 10083 | 0.11 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2015 | 604 | 0.11 | Why? |
| Aortic Valve | 1 | 2017 | 664 | 0.11 | Why? |
| Protein Conformation | 2 | 2018 | 4386 | 0.10 | Why? |
| Laboratories | 2 | 2020 | 2858 | 0.10 | Why? |
| Waste Water | 1 | 2021 | 2185 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2018 | 1046 | 0.10 | Why? |
| Carcinoma, Hepatocellular | 2 | 2017 | 1222 | 0.10 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.10 | Why? |
| Humans | 44 | 2021 | 930598 | 0.10 | Why? |
| Amino Acid Sequence | 2 | 2018 | 6049 | 0.10 | Why? |
| Adaptive Immunity | 2 | 2018 | 2585 | 0.10 | Why? |
| Environmental Monitoring | 1 | 2021 | 3143 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.09 | Why? |
| Urinary Bladder Neoplasms | 1 | 2015 | 614 | 0.09 | Why? |
| Liver Neoplasms | 2 | 2017 | 1666 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2017 | 3607 | 0.08 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.08 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.08 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.08 | Why? |
| Ethiopia | 2 | 2021 | 1222 | 0.08 | Why? |
| Communicable Diseases | 1 | 2021 | 2148 | 0.08 | Why? |
| Molecular Dynamics Simulation | 1 | 2018 | 4155 | 0.07 | Why? |
| Phylogeny | 5 | 2021 | 13341 | 0.07 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.07 | Why? |
| Phosphorylation | 2 | 2018 | 1060 | 0.07 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.06 | Why? |
| Models, Statistical | 1 | 2021 | 5312 | 0.06 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.06 | Why? |
| Nigeria | 2 | 2021 | 2292 | 0.06 | Why? |
| Tuberculosis | 1 | 2019 | 2895 | 0.06 | Why? |
| Viral Proteins | 2 | 2021 | 7370 | 0.06 | Why? |
| Serine Endopeptidases | 1 | 2018 | 4606 | 0.06 | Why? |
| Taiwan | 2 | 2021 | 2556 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.06 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.06 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.05 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Whole Genome Sequencing | 2 | 2021 | 3239 | 0.05 | Why? |
| Bodily Secretions | 1 | 2020 | 109 | 0.05 | Why? |
| Chromatography, Thin Layer | 1 | 2019 | 37 | 0.05 | Why? |
| Mediterranean Region | 1 | 2020 | 276 | 0.05 | Why? |
| Gene Deletion | 1 | 2021 | 430 | 0.05 | Why? |
| Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2018 | 19 | 0.05 | Why? |
| Genes, erbB-1 | 1 | 2017 | 5 | 0.05 | Why? |
| Pregnancy Trimester, First | 1 | 2020 | 366 | 0.05 | Why? |
| Polyproteins | 1 | 2021 | 814 | 0.04 | Why? |
| Viral Hepatitis Vaccines | 1 | 2017 | 58 | 0.04 | Why? |
| Rabbits | 1 | 2021 | 1171 | 0.04 | Why? |
| STAT2 Transcription Factor | 1 | 2018 | 141 | 0.04 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.04 | Why? |
| Linezolid | 1 | 2017 | 160 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2019 | 360 | 0.04 | Why? |
| STAT1 Transcription Factor | 1 | 2018 | 313 | 0.04 | Why? |
| Adolescent | 5 | 2019 | 86841 | 0.04 | Why? |
| Mosquito Vectors | 1 | 2019 | 351 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Chikungunya virus | 1 | 2019 | 339 | 0.04 | Why? |
| Immunocompetence | 1 | 2017 | 280 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Genes, Viral | 1 | 2021 | 1428 | 0.04 | Why? |
| Indonesia | 1 | 2019 | 1022 | 0.03 | Why? |
| Fibula | 1 | 1993 | 9 | 0.03 | Why? |
| Conserved Sequence | 1 | 2017 | 751 | 0.03 | Why? |
| Caco-2 Cells | 1 | 2018 | 1236 | 0.03 | Why? |
| Neoplasm Grading | 1 | 2015 | 400 | 0.03 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.03 | Why? |
| Protein Processing, Post-Translational | 1 | 2017 | 634 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| Health Priorities | 1 | 2021 | 959 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| Interferon-beta | 1 | 2018 | 979 | 0.03 | Why? |
| Intestines | 1 | 2018 | 817 | 0.03 | Why? |
| Cell Survival | 1 | 2017 | 1581 | 0.03 | Why? |
| Organoids | 1 | 2018 | 840 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.03 | Why? |
| Dengue Virus | 1 | 2019 | 910 | 0.03 | Why? |
| Heart Valve Prosthesis | 1 | 2017 | 533 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Microvessels | 1 | 2015 | 490 | 0.03 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 711 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Interferon-alpha | 1 | 2018 | 1442 | 0.03 | Why? |
| Datasets as Topic | 1 | 2017 | 1404 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2019 | 2290 | 0.02 | Why? |
| Software | 1 | 2021 | 2501 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Neoplasm Staging | 1 | 2015 | 1999 | 0.02 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.02 | Why? |
| Male | 9 | 2021 | 367725 | 0.02 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2015 | 2275 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2019 | 22971 | 0.02 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.02 | Why? |
| Disaster Planning | 1 | 2020 | 1680 | 0.02 | Why? |
| Pregnant Women | 1 | 2020 | 2535 | 0.02 | Why? |
| Health Promotion | 1 | 2020 | 2020 | 0.02 | Why? |
| Child | 4 | 2021 | 70012 | 0.02 | Why? |
| Child, Preschool | 3 | 2019 | 36283 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2019 | 53120 | 0.02 | Why? |
| Interferons | 1 | 2018 | 2885 | 0.02 | Why? |
| Feces | 1 | 2019 | 4235 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Models, Molecular | 1 | 2017 | 7616 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.01 | Why? |
| Logistic Models | 1 | 2015 | 9089 | 0.01 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.01 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Aged | 4 | 2019 | 215776 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Bone Cysts | 1 | 1993 | 1 | 0.01 | Why? |
| Pseudarthrosis | 1 | 1993 | 4 | 0.01 | Why? |
| External Fixators | 1 | 1993 | 3 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Fractures, Stress | 1 | 1993 | 13 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Fracture Healing | 1 | 1993 | 37 | 0.01 | Why? |
| Tibia | 1 | 1993 | 72 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Femur | 1 | 1993 | 100 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Osteomyelitis | 1 | 1993 | 131 | 0.01 | Why? |
| Prognosis | 1 | 2015 | 32490 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Bone Neoplasms | 1 | 1993 | 287 | 0.01 | Why? |
| Wound Healing | 1 | 1993 | 424 | 0.01 | Why? |
| Retrospective Studies | 2 | 2018 | 105322 | 0.01 | Why? |
| Hospitalization | 1 | 2019 | 54280 | 0.01 | Why? |
| Fractures, Bone | 1 | 1993 | 487 | 0.01 | Why? |
| Graft Rejection | 1 | 1993 | 1766 | 0.00 | Why? |